CovidResearchTrials by Shray Alag


CovidResearchTrials Covid 19 Research using Clinical Trials (Home Page)


Examine the impact of COVID-19 during pregnancyWiki

Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation


Correlated Drug Terms (0)


Name (Synonyms) Correlation

Correlated MeSH Terms (3)


Name (Synonyms) Correlation
D015212 Inflammatory Bowel Diseases NIH 0.50
D003092 Colitis NIH 0.41
D003093 Colitis, Ulcerative NIH 0.41

Correlated HPO Terms (3)


Name (Synonyms) Correlation
HP:0002037 Inflammation of the large intestine HPO 0.50
HP:0002583 Colitis HPO 0.41
HP:0100279 Ulcerative colitis HPO 0.41

There is one clinical trial.

Clinical Trials


1 Obstetric and Perinatal Outcomes of Women With COVID-19: A Prospective Cohort Study

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is currently spreading rapidly around the globe, causing a major public health issue. There is currently very few data about the impact of COVID-19 on pregnancy, and potential in utero infection. This is a prospective observational study of COVID-19 diagnosed pregnant patients. This objective is to examine the impact of COVID-19 during pregnancy on the rates of obstetric and perinatal complications.

NCT04369859 Pregnant Women Behavioral: Examine the impact of COVID-19 during pregnancy

Primary Outcomes

Description: To compare the complications rates of pregnant women tested positive for the SARS-CoV-2 (study group), with reference rates in a Covid-free population.

Measure: Compare the complications rates

Time: 12 months

Secondary Outcomes

Description: To record clinical presentation of pregnant participants with COVID-19 by questionnaire and clinical evaluation

Measure: Clinical presentation

Time: 12 months


No related HPO nodes (Using clinical trials)